Enanta Pharmaceuticals
ENTA
#7334
Rank
NZ$0.78 B
Marketcap
NZ$27.04
Share price
-2.59%
Change (1 day)
139.94%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: NZ$0.78 Billion

As of December 2025 Enanta Pharmaceuticals has a market cap of NZ$0.78 Billion. This makes Enanta Pharmaceuticals the world's 7334th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.78 B245.59%
2024NZ$0.22 B-27.92%
2023NZ$0.31 B-79.44%
2022NZ$1.52 B-32.12%
2021NZ$2.24 B91.62%
2020NZ$1.17 B-35.53%
2019NZ$1.81 B-11.45%
2018NZ$2.05 B29.87%
2017NZ$1.58 B71.61%
2016NZ$0.92 B1.55%
2015NZ$0.90 B-24.94%
2014NZ$1.20 B102.54%
2013NZ$0.59 B

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Enanta Pharmaceuticals was reported to be:

NZ$0.80 Billion
by Nasdaq info icon info icon
NZ$0.80 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AbbVie
ABBV
NZ$694.12 B 88,827.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$847.70 B 108,504.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$202.05 B 25,786.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$447.02 B 57,170.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$188.84 B 24,094.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$456.76 B 58,418.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland